Rama K Mishra

This inventor holds 19 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: Northwestern University, Angion Biomedica Corporation, Decode Genetics Ehf. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rama K Mishra. Retrieved from https://idiyas.com/inventor/rama-k-mishra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 10)

% Patents Active = 63.2

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 47(Granted Patents)

Company Filing History:

9 out of 2,217

Northwestern University

patents

8 out of 26

Angion Biomedica Corporation

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Sigma Receptor Modulators

Cancer Therapy

Antifibrotic Compounds

Kinase Inhibitors

Cytochrome P450 Inhibitors

Heterocycles

C-MYC Targeting

CXCR4 Modulators

Transcription Elongation

Inflammation Treatment

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692236 - Small molecule modulators of sigma-1 and sigma-2 receptors and uses thereof (2026-07-28),

2. 12629424 - Targeting Pleckstrin-2 for treating cancer (2026-05-19),

3. 12564588 - HECT E3 UBIQUITIN LIAGASE INHIBITORS AND USES THEREOF (2026-03-03),

4. 12152007 - Substituted heterocycles as c-MYC targeting agents (2024-11-26),

5. 11504359 - Antifibrotic compounds and uses thereof (2022-11-22),

6. 11453640 - Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy (2022-09-27),

7. 11142504 - Substituted heterocycles as c-MYC targeting agents (2021-10-12),

8. 10851082 - Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2) (2020-12-01),

9. 10435375 - CXCR4 chemokine receptor modulators (2019-10-08),

10. 10414760 - Cytochrome P450 inhibitors and uses thereof (2019-09-17),

11. 10195184 - Antifibrotic compounds and uses thereof (2019-02-05),

12. 10093668 - Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2) (2018-10-09),

13. 9597321 - Antifibrotic compounds and uses thereof (2017-03-21),

14. 9040555 - Antifibrotic compounds and uses thereof (2015-05-26),

15. 8865752 - Cytochrome P450 inhibitors and uses thereof (2014-10-21),

Title: Innovations and Contributions of Rama K Mishra

Introduction

Rama K Mishra is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of pharmaceuticals and therapeutics. With a total of 16 patents to his name, he has made remarkable strides in developing compounds that target critical health issues, particularly in cancer treatment and fibrosis.

Latest Patents

Among his latest patents, one notable invention is titled "Substituted heterocycles as c-MYC targeting agents." This patent discloses substituted heterocycle compounds, including substituted pyrazoles, substituted pyrimidines, and substituted triazoles. These compounds have shown potential in inhibiting c-MYC, making them valuable for therapeutic applications in treating cancer and cell proliferative disorders. Another significant patent is "Antifibrotic compounds and uses thereof," which provides compounds with a general structural formula and their pharmaceutically acceptable derivatives. This invention outlines pharmaceutical compositions and methods for treating conditions involving abnormal or excessive fibrosis.

Career Highlights

Rama K Mishra has worked with notable organizations such as Angion Biomedica Corporation and Northwestern University. His experience in these institutions has allowed him to collaborate on various innovative projects and contribute to advancements in medical research.

Collaborations

Some of his coworkers include Bijoy Panicker and Dong Sung Lim, who have worked alongside him in various research endeavors. Their collaboration has further enhanced the impact of his inventions in the scientific community.

Conclusion

Rama K Mishra's work exemplifies the spirit of innovation in the field of pharmaceuticals. His patents reflect a commitment to addressing critical health challenges through scientific research and development. His contributions continue to influence the landscape of medical therapeutics.

Profile summary based on public USPTO records.